ABA goal data with rare opportunities require a predeclared event definition, exposure window, eligibility rule, ordinary supports, and raw-count reporting. Track scheduled or naturally possible events, time at risk, valid and missed opportunities, prompts, access, partner response, and uncertainty. Avoid manufacturing unnecessary events or treating one success as generalization. Use longer observation, relevant simulations when ethical and valid, component measures, or another evidence source only when each can answer a defined part of the clinical question.
Define exposure before the season begins
Hana's appointment-scheduling opportunity occurs only when an appointment is actually needed and the scheduling route is available. Record the period during which a valid event could occur, the source that confirms it, and any event that was missed because communication, technology, or partner support failed.
Publish counts before percentages
One success in one opportunity is 100 percent but remains one observed event. Report 1 of 1, the exposure period, context, support, and uncertainty. Avoid comparing percentages whose denominators differ sharply without showing the underlying opportunities.
Use proxies only for a bounded question
A role-play may assess tool access or parts of the message but may not reproduce real scheduling pressure, wait times, or partner behavior. Label simulation, teaching, natural events, and generalization probes separately. Do not combine them into one apparent performance rate.
Plan the next ethical evidence step
Extend observation, wait for the next natural event, test a component, improve access, consult another discipline, or retain uncertainty. Never create a costly or distressing appointment need simply to increase the denominator. Immediate safety and health needs follow their own pathways.
Use Hana's topic rule prospectively
ABA goal data with rare opportunities should keep Hana's exposure period and every naturally eligible event visible. Before the season begins, write what will count, how access failures will be classified, and what conclusion remains possible after zero, one, or two events. Review whether a simulation answers only a component question. A small denominator can still support careful description, but it should not carry a broad mastery, generalization, or treatment-effect claim that the observations cannot sustain.
Audit failure modes in Hana's rare-opportunity review plan
Hana's team tests how the rare-opportunity review plan behaves when exposure is low, opportunities change, a value is missing, an observer disagrees, integrity falls, AAC or another ordinary support is unavailable, direct client feedback conflicts with the graph, and a record arrives after review. For each failure, define whether to repair, qualify, defer, escalate, or collect more evidence. Keep the original source and the decision snapshot so later reviewers can reconstruct what happened.
Define the decision test for Hana
Hana's rare-opportunity review plan states the routine decision, urgent exceptions, evidence due, uncertainty that can be tolerated, and consequence of acting too early or too late. It also names a plausible alternative interpretation and the observation that would distinguish it. This makes the review falsifiable enough to guide the next evidence step instead of turning every data pattern into support for the current plan.
Build Hana's source-to-decision record
For Hana, preserve the selected outcome, response definition, observation condition, eligible opportunity or time base, ordinary supports, prompt rules, source data, observer, integrity, access, direct client feedback, clinical interpretation, decision, owner, and version. Separate caregiver report, staff observation, measurement, payer action, and software output. Give every correction or unresolved field a date, reason, author, and status.
Protect access and authority during Hana's review
Hana's review keeps AAC, interpreters, mobility, food, water, bathroom use, prescribed care, health support, rest, relationships, and emergency help available. Obtain required consent and assent when applicable, monitor withdrawal and distress, and follow the governing response process. Qualified clinicians make case-specific clinical decisions within competence, licensure, supervision, payer, and setting boundaries.
Ask eight data-review questions for Hana
Use these questions in the rare-opportunity review plan:
- Which client-selected outcome and clinical decision apply?
- Which response, condition, opportunity, time base, support, prompt, and unit apply?
- Which data are mature, missing, invalid, late, corrected, disputed, or pending?
- Which observer, integrity, access, health, safety, burden, or context issue limits interpretation?
- Which direct client, caregiver, staff, record, assessment, or interdisciplinary source supports the field?
- Which alternative explanation remains credible?
- Which role owns assessment, interpretation, authorization, implementation, supervision, or coverage?
- Which representative observation will test the next decision?
Keep every unresolved item visible with an owner, age, and next action.
A fictional data-review example for Hana
Hana is fictional and involved in making an accessible appointment-scheduling request that occurs only a few times each season. Reviewers freeze 24 event, exposure, eligibility, time-at-risk, support, uncertainty, and next-step fields and complete 15 of 24 by the checkpoint. Any open exposure, response, opportunity, unit, access, observer, integrity, feedback, safety, correction, or decision field remains in the worklist.
The rare-opportunity review plan measures evidence and review completeness. It does not establish efficacy, functional control, diagnosis, medical necessity, authorization, payment, generalization, maintenance, satisfaction, or legal compliance. Concurrent changes and uncontrolled conditions limit causal conclusions.
Use compatible denominators for Hana
Report Hana's mature records divided by records due to mature; valid opportunities measured divided by opportunities scheduled; observer checks meeting the criterion divided by checks due; integrity steps completed divided by steps due; client-feedback actions completed divided by actions due; and decisions closed divided by decisions due. Publish raw counts, percentages, and open-item age. Keep exposure, behavior, access, agreement, integrity, burden, safety, and clinical decisions in separate series.
Apply current professional boundaries to Hana
For Hana's rare-opportunity review plan, the BACB BCBA Test Content Outline covers operational definitions, measurement, validity, reliability, representative sampling, graphing, assessment, client-informed goals, treatment integrity, generalization, maintenance, and data-based decisions. It is examination content rather than a clinical protocol or practice license. The BACB Ethics Code applies to BCBA and BCaBA certificants and applicants; BACB has no separate jurisdiction over organizations or corporations.
The CASP public summary concerns ABA treatment for people diagnosed with autism and points to licensed detailed guidelines. The workflow here is editorial and is not attributed to CASP's licensed content.
Keep evidence claims bounded for Hana
When reading Hana's 15 of 24 review, the WWC Version 5.0 handbook supplies research-review standards rather than universal clinical review, trend, maturity, missing-data, or measurement rules. The evidence-based practice paper integrates evidence, expertise, and client values and context. Research on assent, generalization and maintenance, social validity, and choice informs questions within each paper's limits. ASHA says AAC users should always have access to their tools or devices.
Close Hana's review with accountable follow-up
Ask Hana and relevant stakeholders to review the rare-opportunity review plan through accessible communication. Record the selected state, direct client response, evidence still missing, responsible role, change version, monitoring plan, and next review. Test the interpretation in representative conditions and reopen it when access, health, context, measurement, or priorities change.
Related resources
- How to Detect Ceiling and Floor Effects in ABA Goal Data
- How to Evaluate the Social Validity of an ABA Measure
- How to Compare Counts, Percentages, Rates, and Time in ABA Data
- How to Measure Data-Collection Burden in an ABA Program
Sources
- Behavior Analyst Certification Board, BCBA Test Content Outline, 6th edition
- Behavior Analyst Certification Board, Ethics Code for Behavior Analysts
- Council of Autism Service Providers, ABA Practice Guidelines Version 3.0 public summary
- American Speech-Language-Hearing Association, Augmentative and Alternative Communication
- Institute of Education Sciences, What Works Clearinghouse Procedures and Standards Handbook Version 5.0
- Slocum and colleagues, The Evidence-Based Practice of Applied Behavior Analysis
- Breaux and Smith, Assent in Applied Behaviour Analysis and Positive Behaviour Support
- Snell and colleagues, Twenty Years of Communication Intervention Research
- Schwartz and Baer, Social Validity Assessments: Is Current Practice State of the Art?
- Rajaraman and colleagues, Choice Versus No Choice: Practical Considerations for Increasing Choices